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Abstract
Background: Several randomised clinical trials (RCTs) of analgesics in postoperative pain after traumatic or
orthopaedic surgery (TOS) have been published, but no studies have assessed the quality of these reports. We
aimed to examine the quality of reporting RCTs on analgesics for postoperative pain after TOS.
Methods: Reports of RCTs assessing analgesics in postoperative pain after TOS were systematically searched from
electronic databases. The quality of reports was assessed using the CONSORT checklist (scoring range from 0 to
22). The quality was considered poor when scoring was 12 or lesser. The publication year and the impact factor of
journals were recorded.
Results: A total of 92 reports of RCTs were identified and 69 (75%) scored 12 or lesser in CONSORT checklist
(range 5-17). The mean (SD) CONSORT score of all reports was 10.6 (2.7). Missing CONSORT items included primary
and secondary outcome measures (11%), the specific objectives and hypothesis definition (12%), the sample size
calculation (12%), the dates defining the periods of recruitment (12%), the discussion of external validity of findings
(14%), the allocation sequence generation (24%), and the interpretation of potential bias or imprecision of results
(25%). There was a little improvement in CONSORT scores over time (r = 0.62; p < 0.001) and with impact factor of
journals (r = 0.30; p < 0.001).
Conclusion: Quality of reporting RCTs on analgesics after TOS is poor. Reporting of those RCTs should be
improved according to methodological standard checklists in the next years.
Background
Traumatic and orthopaedic surgery (TOS) is one of the
most painful surgical interventions. Evidence on the effi-
cacy of analgesic drugs for pain after TOS is usually
obtained from randomised clinical trials (RCTs). How-
ever, interpretation of results can be hampered by
incomplete data reporting and by low methodological
quality of the trial [1]. The quality of the evidence pro-
vided by orthopaedic journals about major orthopaedic
surgery has been assessed, [2,3] as well as the quality of
the RCTs assessing analgesic interventions [4]. We have
assessed characteristics of patients included in RCTs on
analgesics drugs for pain after TOS, as well as analgesic
drugs, outcomes and observation periods in a previous
study [5]. Nevertheless, quality in reporting RCTs of
analgesics for postoperative pain after TOS has not been
systematically assessed. The aim of this study was to
examine the quality of reporting RCTs on the efficacy of
analgesic drugs in postoperative pain after TOS.
Methods
Data sources and searching
A systematic review assessing quality of RCTs of analge-
sic drugs in pain after TOS was performed. A search
from electronic databases PubMed, EMBASE, and The
Cochrane Library, and references from identified papers
and hand searches were carried out. The search
included combinations of the following MeSH terms:
“pain, postoperative”, “randomised controlled trials”,
“analgesics”, “anti-inflammatory agents, non steroidal”,
and “orthopaedics”.
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Selection criteria
RCTs of analgesic drugs for the control of pain after
TOS published from January 1966 to June 2006 were
included. The language of the reports was restricted to
English, French, Italian, German, and Spanish. Reports
of clinical trials in adult patients were included if they
were parallel group studies, and if patients had been
randomly allocated to the various treatment groups
(either opioids, paracetamol, or non-steroidal anti-
inflammatory drugs [NSAIDs], combinations of them or
placebo), exclusively after TOS, and the route of drug
administration was either oral, intramuscular, intrave-
nous, subcutaneous, rectal, or transcutaneous. Only full
original articles were considered for inclusion. Case
reports, abstracts, and letters were excluded. RCTs on
anaesthetics, on preoperative or perioperative drug
administration, and on spinal drug administration, and
those on patients undergoing disc surgery were all
excluded.
Data abstraction and study characteristics
The following data were extracted from each report:
language, year of publication, geographical area where
the study was carried out, medical journal, its impact
factor, and its medical area. The quality of reporting of
each included study in the reports was assessed inde-
pendently by three evaluators (EM, AV, CA) with CON-
SORT checklist [6]. The quality in reporting trials was
scored according to the revised CONSORT checklist,
which includes 22 items assessing the quality of the con-
tents of the report (Title and Abstract, Introduction,
Methods, Results, and Discussion). Discrepancies
between the evaluators were discussed and resolved by
consensus.
The quality of RCTs was classified in three categories
according to CONSORT score: excellent (≥ 20 items),
good (between 13 and 19), and poor (≤ 12).
The impact factor, for each journal where the RCTs
were published, was determined from the Science Cita-
tions Index (http://www.accesowok.fecyt.es/, last
accessed March 23, 2009). The RCTs from journals
without a citation index were excluded from the impact
factor median and correlation analysis. The RCTs were
considered to be from high-impact journals if the cita-
tion index was above the median of the journals
included in the study, low-impact journals if the citation
index was below the median and no-impact journals if
they didn’t have a citation index. These three categories
were used for the comparative analysis between quality
scales.
Statistical analysis
Mean (SD), median (range), and frequencies were used
as descriptive statistics according to the variable charac-
teristics. Comparison of the mean overall scores for
CONSORT checklist according to compared groups in
RCTs (with placebo or without placebo group, and with
different compared analgesics) was carried out with
ANOVA analysis. The Spearman correlation was used
for correlations between the overall scores of each trial
in the CONSORT checklist and the year of publication,
and the impact factor of the journal where the report
had been published. Comparisons between overall score
in the CONSORT checklist and impact factor of the
journals were carried out with ANOVA analysis; p-
values were adjusted using the Bonferroni method. Sta-
tistical significance was considered when p-values were
less than 0.05. Agreement between evaluators was
assessed with intraclass correlation coefficient and 95%
confidence intervals (ICC and 95% CI). We accepted the
definition of a high level of agreement represented by
values of ICC from 0.65 [7]. All analyses were con-
ducted using SPSS 12.0 (SPSS Inc, Chicago IL, USA).
Results
A total of 326 reports were selected, and 235 were
excluded because the studies were not RCTs, orthopae-
dic surgery was combined with another type of surgery,
non analgesic drugs were also assessed, and for other
reasons. Ninety-one publications reporting 92 RCTs met
inclusion criteria (one publication reported two RCT).
Eighty four (91.3%) were published in English, six (6.5%)
in French, and two (2.2%) in Italian. The first report had
been published in 1971, and 49 (53.3%) had been pub-
lished after 1990. The articles described 58 RCTs carried
out in Europe (63%), 26 in America (26; 28.3%), 5 in
Asia (5.4%), and 3 in Africa (3.3%). Reports were pub-
lished in 46 medical journals from different medical
areas, mainly Pharmacology and Therapeutics 32 (35%),
and Anaesthesiology 26 (28%). A total of 76 (82.6%)
RCTs were published in 34 journals included in the
Science Citation Index. The median impact factor was
1.76 (range 0.31 - 7.53). Thirty-six reports had been
published in low-impact journals, and 40 in high-impact
journals.
The agreement (ICC) between the three evaluators for
the overall scores of the CONSORT checklist assessed
was 0.77 (95%CI, 0.70 - 0.84). The mean (SD) CON-
SORT checklist score was 10.5 (2.7). The CONSORT
checklist score ranged from 5 to 17. The quality of
RCTs was good in 23 (25%) reports and poor in 69
(75%). The details of the scores of the items in the
CONSORT checklist are given in Table 1. In the Meth-
ods section the following items were poorly described:
outcomes (ten trials, 10.9%), objectives and hypothesis
(11 trials, 12%), sample size calculation (11 trials, 12%),
and the sequence generation of randomisation (22 trials,
23.9%). In the Results section the dates defining the per-
iods of recruitment and follow-up only were reported in
11 trials (12%). The analysis of outcomes was by
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intention to treat and the number of participants
included in each analysis was reported in 24 trials
(26%). The estimated effect size of the outcomes and its
precision was described in 40 (43.5%). In the Discussion
section, the external validity of the trials findings only
were commented in 13 trials (14.1%), and the interpreta-
tion of the results, taking into account hypothesis,
sources of potential bias or imprecision, and the dangers
associated with multiplicity of analysis and outcomes
was adequately described in 23 trials (25%). Differences
in reporting were observed between RCTs that included
a placebo control group and those without a placebo
group. The mean scores in RCTs with placebo group
were higher than in RCTs without placebo group. No
differences in reporting were shown related to different
analgesics groups compared in RCTs (Table 2).
The correlation between the mean overall CONSORT
scores and the year of publication was statistically signif-
icant (r = 0.62; p < 0.001), as well as between the mean
overall CONSORT scores and the impact factor (r =
0.30; p < 0.001). The mean (SD) CONSORT scores for
RCTs published after 2001 (year CONSORT checklist
was published) was higher than the mean CONSORT
scores for those published previously [14.4 (2) and 10.3
(2.5) respectively; p < 0.0001]. The mean overall score in
the CONSORT checklist was higher in high-impact
journals. Differences were statistically significant in the
mean overall CONSORT score for low and no-impact
journals compared to high-impact journals (Table 3).
Discussion
The results of the present study illustrate that the over-
all quality of reporting of RCTs assessing the efficacy of
analgesic drugs after TOS was poor. The main deficien-
cies were lack of information on methods to define the
hypothesis and the outcomes, the sample size calcula-
tion, and lack of data on the results of estimated effects
size and their precision. These methodological flaws
limit their validity and the interpretation of the results,
and they may lead to biased findings [1,8]. In fact, few
reports adequately interpreted the results of RCTs in
discussion section, taking into account sources of
Table 1 Reporting randomised controlled clinical trials according to different items in CONSORT checklist.
Paper section and Topic Item number n RCTs
(N = 92)
(%)
Title and abstract 1 64 (69.6)
Introduction
Background 2 67 (72.8)
Methods
Participants 3 86 (93.5)
Interventions 4 90 (97.8)
Objectives 5 11 (12.0)
Outcomes 6 10 (10.9)
Sample size 7 11 (12.0)
Randomisation
Sequence generation 8 22 (23.9)
Allocation concealment 9 5 (5.4)
Implementation 10 1 (1.1)
Blinding (masking) 11 75 (81.5)
Statistical methods 12 84 (91.3)
Results
Participant flow 13 62 (67.4)
Recruitment 14 11 (12.0)
Baseline data 15 73 (79.3)
Numbers analysed 16 24 (26.0)
Outcomes and estimation 17 40 (43.5)
Ancillary analyses 18 48 (52.2)
Adverse events 19 88 (95.6)
Discussion
Interpretation 20 23 (25.0)
Generalization 21 13 (14.1)
Overall evidence 22 62 (67.4)
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potential bias or imprecision, the problems associated
with multiplicity of analysis and outcomes or the exter-
nal validity of findings. Our results are similar to those
of other systematic reviews on the methodological qual-
ity in orthopaedic-surgery related topics,[3] and on
analgesic interventions [4]. However, the results also
show that there has been a small and progressive
improvement in the quality of reporting of RCTs over
time, as described in studies in other therapeutic areas
[9-13]. In general, our results indicate that editors and
reviewers of journals, as well as readers, should be more
aware of the methodological shortcomings in the reports
of RCTs evaluating analgesic drugs in postoperative after
TOS. We think that most of those methodological defi-
ciencies in reporting RCTs, could be easily corrected
and avoided in the future.
Three approaches have been developed to assess the
quality of RCTs: one based on specifically relevant indi-
vidual components (which evaluate selected aspects of
trials, such as randomisation or blinding), scales (provid-
ing numerical scores of quality), and checklists (that
involve lists of items such as CONSORT or Delphi)
[14]. The journal impact factor has also been used
widely as a quality measure [15]. In our opinion, the
CONSORT checklist helps to evaluate quality in a more
accurate way because it includes other important meth-
odological items such as the hypothesis description,
definition of the primary and secondary outcomes, sam-
ple size calculation, and others. On the other hand, we
expected that journals with the highest impact factors
would have the highest scientific quality [16]. Bath et al.
[10] have reported a significant association between the
CONSORT score and the impact factor in stroke. When
we classified the medical journals according to the
impact factor (none, low, or high), the CONSORT score
was higher in high-impact journals than non-impact
journals. Since the reporting guidelines such as the
CONSORT checklist, or the Standards for Reporting in
Trials (SORT) -focused on reporting side effects- were
published or endorsed as a requirement for publishing,
reports of clinical research have improved [17,18]. But
in fact, in 2003 only 22% of high impact journals had
endorsed it,[19] and there are still many journals in
anaesthesiology, pain, or orthopaedic topics that have
not done so.
Assessment of the methodological quality and report-
ing has been carried out in other specialities and/or in
other conditions [9-13,20-33]. In general, the quality of
reporting of RCTs was low or less than optimal, with
more than half of all studies scoring less than half of the
scores from the quality scales used with the exception of
two studies which were adequately reported [13,32].
However, these studies have used a variety of instru-
ments based on different criteria (ranging from 1 to
more than 80 items). The CONSORT checklist and the
Jadad scale were the most frequently used, as well as
modified versions of both [34]. Therefore, it is not pos-
sible to make a direct comparison with the results of
our study. Most of the referred studies have assessed
clinical trials published in specific medical journals
(basically assessing the quality of those journals), while
the present study focused on a specific problem.
We limited the bias in the selection and in scoring the
methodological quality of RCTs by conducting process
in triplicate and independently [35]. As available scales
and checklists are heterogeneous in size and complexity,
their overall scores can also diverge considerably
depending on the evaluator [36,37]. However, our
results showed high agreement between evaluators in
the overall scores of the quality checklist. The CON-
SORT checklist is not a quality scale but as it gives
recommendations on reporting, it provides an
unweighted score of reporting compliance, where some
items may be clearly more important than others. More-
over, its relevance can vary depending on the condition
being assessed (e.g., blinding is crucial in RCTs on the
treatment of pain, but less so on those in the treatment
Table 3 Mean (SD) overall scores for CONSORT checklist
according to impact factor (IF) of the medical journals.
IF
journals
No IF
journals
(n = 16)
Low
IF journals
(n = 36)
High
IF journals
(n = 40)
Total
journals
(N = 92)
CONSORT
Mean (SD)
8.9 (2.3)† 10.1 (2.1)†† 11.6 (3.0) 10.5 (2.7)
† p = 0.007 no IF journals vs. high IF journals; †† p = 0.012 low IF journals vs.
high IF journals
Table 2 Quality of reporting according to compared
groups in randomised clinical trials.
RCT (n = 92) CONSORT checklist
Mean score (sd)
Placebo control group
Yes (n = 42) 11.36 (2.59)
No (n = 50) 9.92 (2.67)
Statistical significance p = 0.011
Analgesics compared
NSAIDs (n = 46) 10.59 (3.01)
Opioids (n = 10) 11.70 (2.31)
NSAIDs vs. Opioids (n = 19) 10.11 (2.28)
NSAIDs + opioids vs. NSAIDs and/
or opioids (n = 17)
10.41 (2.57)
Statistical significance p = 0.511
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of infectious diseases) [10]. Nevertheless, we have used it
because of the lack of a better alternative.
It should also be acknowledged that most of the trials
included in this review were published several years ago
and may no longer reflect current reporting practices.
Furthermore, only published trials were retrieved, and
authors or pharmaceutical companies were not con-
tacted. Unpublished trials tend to be of a lower metho-
dological quality, and their results tend to be more
biased than those of published trials;[38] therefore, the
methodological quality of controlled research on analge-
sics in TOS may be even worse than described in the
present report.
Conclusions
The quality of reporting RCTs on analgesic drugs after
TOS is inadequate, although a modest improvement has
been seen over time. Therefore, editors and reviewers of
journals, as well as readers, should be more aware of the
shortcomings in reporting RCTs on analgesic drugs in
postoperative pain after TOS. The quality of reporting
RCTs on analgesia in TOS should be improved accord-
ing to standard methodological checklists in the future.
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